These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1153254)
1. [Responsibility for drug reactions]. Naess K Nord Med; 1975 Mar; 90(3):65-6. PubMed ID: 1153254 [No Abstract] [Full Text] [Related]
2. [Responsibility for adverse drug effects]. Naess K Tidsskr Nor Laegeforen; 1971 Mar; 91(9):673-6. PubMed ID: 5576192 [No Abstract] [Full Text] [Related]
3. [Physician's responsibility for the comprehension of adverse drug reactions]. Kimbel KH Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1550-8. PubMed ID: 611878 [No Abstract] [Full Text] [Related]
4. [Work of the committee on drug side effects]. Naes K Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1237-8. PubMed ID: 1162664 [No Abstract] [Full Text] [Related]
5. [Available list of adverse effects]. Liljestrand A Lakartidningen; 1976 Apr; 73(15):1397. PubMed ID: 1263655 [No Abstract] [Full Text] [Related]
6. Package inserts, adverse drug reactions, and the physician's liability. Morrell MX Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773 [No Abstract] [Full Text] [Related]
7. [The doctor's responsibility and risk in the prescribing of drugs]. Aschenbrenner R Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431 [No Abstract] [Full Text] [Related]
8. [Reports on drug side effects for the period 1973-1974]. Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1243-7. PubMed ID: 1162667 [No Abstract] [Full Text] [Related]
9. The Swedish Adverse Drug Reaction Committee: an important tool for safer drug therapy. Böttiger LE QRB Qual Rev Bull; 1981 Feb; 7(2):14-20. PubMed ID: 6785702 [No Abstract] [Full Text] [Related]
10. [Editorial: Information committee of the drug industry]. Naes K Tidsskr Nor Laegeforen; 1975 Oct; 95(30):1748-9. PubMed ID: 1188879 [No Abstract] [Full Text] [Related]
11. [Towards a new drug management]. Hoffmann M; Ahlner J Lakartidningen; 1995 Oct; 92(41):3804, 3807. PubMed ID: 7564634 [No Abstract] [Full Text] [Related]
12. Adverse drug reactions and the P & T committee. Lipman AG Hosp Formul; 1980 Jul; 15(7):580. PubMed ID: 10247654 [No Abstract] [Full Text] [Related]
13. [Liability for drug damages]. Barnikel W Dtsch Med Wochenschr; 1977 Jan; 102(4):139. PubMed ID: 832595 [No Abstract] [Full Text] [Related]
14. [The admission of drugs in the Netherlands]. ten Ham M Ned Tijdschr Geneeskd; 1983 May; 127(22):968-71. PubMed ID: 6866153 [No Abstract] [Full Text] [Related]
15. [Proposal from the Product Liability Committee: Drug insurance for adverse effects from July 1, 1977 to be paid by manufacturers and importers]. Lakartidningen; 1976 May; 73(19):1785-6. PubMed ID: 1271903 [No Abstract] [Full Text] [Related]
16. Surveillance of drug adverse reactions. Campbell JS; Henderson IW Can Med Assoc J; 1972 Jun; 106(12):1285. PubMed ID: 5035130 [No Abstract] [Full Text] [Related]
17. Potential conflict of interest of a pharmacy and therapeutics committee member. Am J Hosp Pharm; 1989 Oct; 46(10):2047-9; discussion 2049-51. PubMed ID: 2816960 [No Abstract] [Full Text] [Related]
19. [Possibilities and limits of drug supervision]. Homann G Med Klin; 1970 Aug; 65(35):1518-20. PubMed ID: 5516116 [No Abstract] [Full Text] [Related]
20. [Criteria for choice of preparations in a drug committee]. Lunde PK Tidsskr Nor Laegeforen; 1975 Jan; 95(1):37-40. PubMed ID: 1111161 [No Abstract] [Full Text] [Related] [Next] [New Search]